All In: Biotech

What’s not to like about the biotech sector right now? The earnings have been very strong with Amgen, Genentech, Gilead, Celgene and Biogen Idec delivering strong results. Don’t forget about all the M&A activity. Genzyme is acquiring AnorMed, Gilead is buying Myogen and just today, Merck is taking out Sirna Therapeutics. You have a perfect scenario in the biotech sector. The supply of stock is dwindling with the M&A activity, a few stock buybacks and strong earnings from the big guys. I’m all in... I currently have positions in the following biotech companies: Amgen, Biogen Idec, Celgene, Genentech, Genzyme, Invitrogen, Qiagen and Vertex Pharmaceuticals.